-+ 0.00%
-+ 0.00%
-+ 0.00%

BMO Capital Maintains Outperform on Chemours, Lowers Price Target to $18

Benzinga·08/13/2026 12:22:39
Listen to the news
BMO Capital analyst John McNulty maintains Chemours (NYSE:CC) with a Outperform and lowers the price target from $26 to $18.